Skip to main content

Table 1 Demographic and laboratory data of studied groups

From: Diagnostic and prognostic value of serum soluble CD163 in cirrhotic patients with hepatitis C virus-related hepatocellular carcinoma before and after locoregional therapy

Parameter

HCC group (n=40)

LC group (n=20)

p

Age (years)

57.1±6.8

54.8±7.6

0.236

BMI (Kg/m2)

24.7±2.1

25.4±3

0.365

Gender

Male n (%)

28 (70%)

12 (60%)

0.439

Female n (%)

12 (30%)

8 (40%)

Child-Pugh class

A n (%)

23 (57.5%)

9 (45%)

0.305

B n (%)

17 (42.5%)

10 (50%)

C n (%)

0 (0.0%)

1 (5%)

ALT (U/L)

57.0±28.3

40.2±17.3

0.006

AST (U/L)

57.9±31.0

30.9±17.1

< 0.001

ALP (U/L)

79.2±23.6

88.4±30.7

0.25

S. albumin (g/dl)

3.6±0.4

3.4±0.6

0.156

T. bilirubin (mg/dl)

1.5±0.4

1.7±0.6

0.13

D. bilirubin (mg/dl)

0.7±0.2

0.9±0.4

0.117

INR

1.4±0.38

1.31±0.37

0.37

Hemoglobin (g/dL)

11.0±1.5

10.3±0.9

0.022

WBCs (× 103/mL)

7±2.3

5.6±1.4

0.28

Platelets (× 103/mL)

148.0±36.5

137.4±41

0.313

S. creatinine (mg/dL)

0.85±0.32

0.79±0.32

0.516

S. sodium (mEq/L)

137.6±3.8

136.3±3.1

0.187

S. potassium (mEq/L)

4.0±0.5

4.2±0.4

0.129